Clinical Trial Update: Immunotherapy for Patients With Brain Stem Glioma and Glioblastoma [Phase 1]

View source ↗

Summary

Phase 1 clinical trial investigating an immunotherapy approach for brainstem glioma and glioblastoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brainstem Glioma
• Glioblastoma

Snippet

Sponsor: Cedars-Sinai Medical Center | Conditions: Brain Stem Glioma, Glioblastoma | Phase 1 | Status: COMPLETED